Regulus Therapeutics Inc (RGLS)
2.42
+0.15
(+6.61%)
USD |
NASDAQ |
Apr 26, 15:39
Regulus Therapeutics Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2020 | 0.06M |
| December 31, 2019 | 6.832M |
| September 30, 2019 | 6.832M |
| June 30, 2019 | 6.832M |
| March 31, 2019 | 6.832M |
| December 31, 2018 | 0.072M |
| September 30, 2018 | 0.072M |
| June 30, 2018 | 0.072M |
| March 31, 2018 | 0.072M |
| December 31, 2017 | 0.072M |
| September 30, 2017 | 0.072M |
| June 30, 2017 | 0.258M |
| March 31, 2017 | 0.723M |
| December 31, 2016 | 1.194M |
| September 30, 2016 | 12.04M |
| June 30, 2016 | 13.70M |
| Date | Value |
|---|---|
| March 31, 2016 | 17.05M |
| December 31, 2015 | 20.76M |
| September 30, 2015 | 14.12M |
| June 30, 2015 | 13.34M |
| March 31, 2015 | 10.24M |
| December 31, 2014 | 7.669M |
| September 30, 2014 | 8.904M |
| June 30, 2014 | 13.94M |
| March 31, 2014 | 17.96M |
| December 31, 2013 | 19.57M |
| September 30, 2013 | 17.35M |
| June 30, 2013 | 14.04M |
| March 31, 2013 | 12.59M |
| December 31, 2012 | 12.70M |
| September 30, 2012 | 12.82M |
| June 30, 2012 | 13.82M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.06M
Minimum
Mar 2020
6.832M
Maximum
Jun 2019
5.139M
Average
6.832M
Median
Jun 2019
Revenue (TTM) Benchmarks
| ACADIA Pharmaceuticals Inc | 726.44M |
| ADMA Biologics Inc | 258.22M |
| FibroGen Inc | 147.75M |
| Protara Therapeutics Inc | -- |
| Amylyx Pharmaceuticals Inc | 380.79M |